Press Releases

Biopharma PEG, a leading provider of polyethylene glycol (PEG) derivatives, is proud to introduce an extended Azide PEG series that includes monodispersed, polydispersed, and multi-arm PEGs. This innovative product line is set to transform biomedical research by offering researchers a diverse range of PEGylation options for enhanced precision and flexibility.

The Azide PEG series now features an extensive selection of monodispersed PEGs, including but not limited to: N3-PEG4-OH, N3-PEG3-COOH, N3-PEG11-NH2, N3-PEG3-NHS ester, 2-((Azido-PEG8-carbamoyl)methoxy)acetic acid, etc. These monodispersed Azide PEGs are employed in bioconjugation reactions, allowing the attachment of specific ligands, peptides, or other biomolecules to improve the targeting and therapeutic efficacy of drugs.

In addition, the polydispersed Azide PEGs, such as mPEG-N3, N3-PEG-N3, Silane-PEG-N3, SH-PEG-N3, provide researchers with a broader spectrum of choices, enabling them to tailor PEGylation strategies to specific project requirements.

Furthermore, Biopharma PEG introduces multi-arm azide PEGs, exemplified by 4-ArmPEG-N3, which enhances the versatility of PEGylation processes for researchers working on multi-functional drug delivery systems and other advanced applications.

Dr. Zhang, Chief Scientist at Biopharma PEG, commented on the expanded Azide PEG series, stating, "We are excited to present this comprehensive range of Azide PEGs to the scientific community. By offering monodispersed, polydispersed, and multi-arm options, we aim to provide researchers with the tools they need to innovate in drug development, diagnostics, and beyond."

This expanded Azide PEG series reinforces Biopharma PEG's commitment to providing cutting-edge solutions for the scientific community, empowering researchers to make breakthroughs in their fields.

For more information about Biopharma PEG's Azide PEG series and other products, please visit https://www.biochempeg.com/.

About Biopharma PEG

Biopharma PEG is a leading supplier of polyethylene glycol (PEG) derivatives, dedicated to advancing biomedical research by delivering high-quality products tailored to meet the evolving needs of scientists and researchers. The company's commitment to innovation and collaboration has positioned it at the forefront of the biotechnology industry.

For media inquiries, please contact:

Biopharma PEG Scientific Inc.

TEL: 1-857-366-6766

Fax: 617-206-9595

Email: sales@biochempeg.com